Finnish studio Remedy issues profit warning due to weak sales of co-op shooter FBK: Fiery Breakthrough.
Note to investorsThe company explained that it had lowered its long-term sales forecast for the game and subsequently recognized a non-cash impairment charge of €14.9 million ($17.2 million).
This figure represents the majority of capitalized development costs and allocated acquired publishing and distribution rights. Remedy said the impairment did not impact its cash position.
Remedy is struggling to find an audience for FBK: Fiery Breakthroughwhich was released on June 17 on PC and console platforms. A shooter that is very similar Alan Wake And Control is part of the company's interconnected universe, which attracted 1 million players in 10 days.
However, in August, Remedy explained that many players were quickly abandoning the title and confirmed. fire barrier There were problems on Steam.
“From a commercial perspective, we were unhappy with consumer sales at launch. FBK: Fiery Breakthrough. Still, FBC: Firebreak's Commercial performance was largely driven by the Xbox and PlayStation subscription service agreements.” the company said at the time.
“Sales did not meet internal Remedy goals.”
Remedy insisted FBK: Fiery Breakthrough may succeed despite this “rocky start”, but is obviously struggling to rehabilitate the title.
“FBK: Fiery Breakthrough was launched on June 17. In its 2025 half-year financial report, Remedy said that FBC: Firebreak's Consumer sales were weaker during the launch phase. Since launch, the company has quickly developed the game based on player feedback and released numerous updates,” the company said in an investor note released today.
“On September 29, Remedy released the first major update called Breakpoint for FBK: Fiery Breakthroughwhich made significant changes to the core gameplay. Despite improved player performance and sales following the update, sales did not meet Remedy's internal goals.”
Remedy CEO Tero Virtala said the company will “balance future investments” in FBK: Fiery Breakthrough continue to maintain and improve this experience in line with the updated sales forecast.
As noted in its updated 2025 sales forecast, Remedy still expects revenue to increase year over year, but says operating income will now be negative and lower than the prior year.